RE: Interesting article posted on the Telegram board30 Apr 2024 18:33
Https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.34978
Just look at the Companies mentioned in this article:-
***Elena Ioana Braicu receives research funding from Bayer, Roche Diagnostics, Tesaro, GSK, and AstraZeneca and personal fees from AstraZeneca, Clovis, GSK, Tesaro, EISAI, RochePharma, and Roche Diagnostics. Elena Ioana Braicu is a Feodor Lynen fellow of the Humboldt Foundation and a participant in the Charité Clinical Scientist Program funded by the Charité Universitätsmedizin Berlin and the Berlin Institute of Health.
***Philipp Harter receives research funding from Astra Zeneca, Roche, GSK, Genmab, DFG, European Union, DKH, Immunogen, Seagen, Clovis, and Novartis and honoraria from Amgen, Astra Zeneca, GSK, Roche, Sotio, Stryker, Zai Lab, MSD, Clovis, Eisai, Mersana, and Exscientia.
***Philipp Harter is ******an advisory board member******* for Astra Zeneca, Roche, GSK, Clovis, Immunogen, MSD, Miltenyi, Novartis, and Eisai!!!!!!!!!!!!!!!*************.
All IMHO.